After years of protesting against Pfizer and GlaxoSmithKline’s pneumococcal vaccine pricing, Médecins Sans Frontières is empowering pharma investors to get involved.
Even after Pfizer and GlaxoSmithKline offered up pneumonia vaccine pricing concessions last fall, Médecins Sans Frontières isn’t letting up in its public pressure campaign against the drugmakers.